Skip to main content
SpringerLink
Log in

HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb–Drug Interactions

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Herbal food supplements are commonly used and can be an important part of patient self-care. Like all other bio-active and therapeutic products, they have a benefit/risk balance. These products are not without adverse effects and potentially interact with other therapies. Educating patients and providing information for health professionals about the risk of herb–drug interactions is key. One of the purposes of the biomedical literature is to inform prescribers. Scientific literature accessible on databases such as PubMed is dense and careful reading is time consuming. We propose a reading aid tool named “HDI highlighter” to help readers to find key information in clinical studies and case reports describing herb–drug interactions. It uses natural language processing algorithms (artificial intelligence) with a pharmaceutical focus. Semantic relation extraction for herb–drug interactions from the biomedical literature are overexpressed using keywords. We have tested it to review 120 published articles over the last 10 years. In these articles, we have shown that case reports often involved long-term or semi-long-term treatments such as cancer or human immunodeficiency virus therapies, antiepileptic drugs, or central nervous system drugs. Similarly, these classes of drugs are more extensively targeted by clinical studies. Herb–drug interactions described in case reports are identified in medicinal, recreational, and alimentary uses. They also usually lack a rigorous description of the herb(s) involved. Typically, clinical studies provide a complete description of protocols and dosages, with a few exceptions explained by patients’ needs. Clinical studies on herbs are nevertheless conducted on a limited number of patients. All these limitations make the interpretation of herb–drug interactions complicated, but the HDI highlighter provides a quick overview of the herb–drug interaction literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Canales-Ronda P, Küster-Boluda I, Vila-López N. Healthy lifestyle and complementary and alternative medicine. Holistic Nurs Pract. 2021. https://doi.org/10.1097/HNP.0000000000000476.

    Article  Google Scholar 

  2. Gong M, Dong H, Tang Y, Huang W, Lu F. Effects of aromatherapy on anxiety: a meta-analysis of randomized controlled trials. J Affect Disord. 2020;274:1028–40.

    Article  PubMed  Google Scholar 

  3. Miyasaka LS, Atallah ÁN, Soares B. Passiflora for anxiety disorder. Cochrane Database Syst Rev. 2007;1:CD004518.

    Google Scholar 

  4. Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. 2014; p. CD006206.

  5. Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012; p. CD007170.

  6. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012; p. CD001321.

  7. Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015; p. CD007575.

  8. Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytother Res. 2018;32:1147–62.

    Article  PubMed  Google Scholar 

  9. Renet S, de Chevigny A, Hoacoglu S, Belkarfa A-L, Jardin-Szucs M, Bezie Y, et al. Risk evaluation of the use of complementary and alternative medicines in cancer. Ann Pharm Fr. 2021;79:44–52.

    Article  CAS  PubMed  Google Scholar 

  10. Riaz U, Iqbal S, Sohail MI, Samreen T, Ashraf M, Akmal F, et al. A comprehensive review on emerging importance and economical potential of medicinal and aromatic plants (MAPs) in current scenario. Pak J Agric Res. 2021;34:381–92.

    Google Scholar 

  11. Grimm D, Mathes S, Woelber L, Van Aken C, Schmalfeldt B, Mueller V, et al. Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany. Arch Gynecol Obstet. 2021;303:1315–30.

    Article  CAS  PubMed  Google Scholar 

  12. Stritter W, Rutert B, Eidenschink C, Eggert A, Längler A, Holmberg C, et al. Perception of integrative care in paediatric oncology-perspectives of parents and patients. Complement Ther Med. 2021;56: 102624.

    Article  PubMed  Google Scholar 

  13. Teschke R, Schulze J. Pharmakovigilanz und herbale Hepatotoxizität: kritische Aspekte und Lösungswege. Dtsch Med Wochenschr. 2013;138:281–4.

    Article  CAS  PubMed  Google Scholar 

  14. Barnes J. Pharmacovigilance of herbal medicines : a UK perspective. Drug Saf. 2003;26:829–51.

    Article  PubMed  Google Scholar 

  15. Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, et al. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective. J Ethnopharmacol. 2012;140:519–25.

    Article  PubMed  Google Scholar 

  16. Babos MB, Heinan M, Redmond L, Moiz F, Souza-Peres JV, Samuels V, et al. Herb–drug interactions: worlds intersect with the patient at the center. Medicines. 2021;8:44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Farah MH, Olsson S, Bate J, Lindquist M, Edwards R, Simmonds MSJ, et al. Botanical nomenclature in pharmacovigilance and a recommendation for standardisation. Drug Saf. 2006;29:1023–9.

    Article  PubMed  Google Scholar 

  18. Kazi SE, Karia R, Leontieva L. Herbal supplements: can they cause hypomania? Cureus. 2021;13: e13476.

    PubMed  PubMed Central  Google Scholar 

  19. Melchardt T, Magnes T, Weiss L, Grundbichler M, Strasser M, Hufnagl C, et al. Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. BMC Complement Altern Med. 2014;14:115.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Naccarato M, Yoong D, Gough K. A potential drug-herbal interaction between Ginkgo biloba and efavirenz. J Int Assoc Physicians AIDS Care. 2012;11:98–100.

    Article  Google Scholar 

  21. Chan JCM, Ng M-H, Wong RSM, Tomlinson B. A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana. J Clin Pharm Ther. 2019;44:381–3.

    Article  PubMed  Google Scholar 

  22. Yang P, He F, Tan M, Zhong F, Liao X, Li Y, et al. Marked decrease of tacrolimus blood concentration caused by compound Chinese herbal granules in a patient with refractory nephrotic syndrome. J Clin Pharm Ther. 2021;46:215–8.

    Article  CAS  PubMed  Google Scholar 

  23. Cattaneo D, Fusi M, Gervasoni C. No effects of Hypericum-containing complex on dolutegravir plasma trough concentrations: a case report. Eur J Clin Pharmacol. 2019;75:1467–8.

    Article  PubMed  Google Scholar 

  24. Uygur Bayramıçlı O, Kalkay MN, Oskay Bozkaya E, Doğan Köse E, Iyıgün O, Görük M, et al. St. John’s wort (Hypericum perforatum) and warfarin: dangerous liaisons! Turk J Gastroenterol. 2011;22:115.

    Article  PubMed  Google Scholar 

  25. Cordova E, Morganti L, Rodriguez C. Possible drug-herb interaction between herbal supplement containing horsetail (Equisetum arvense) and antiretroviral drugs. J Int Assoc Provid AIDS Care. 2017;16:11–3.

    Article  PubMed  Google Scholar 

  26. Daveluy A, Géniaux H, Thibaud L, Mallaret M, Miremont-Salamé G, Haramburu F. ProbableiInteraction between an oral vitamin K antagonist and turmeric (Curcuma longa). Therapie. 2014;69:519–20.

    Article  PubMed  Google Scholar 

  27. Nayeri A, Wu S, Adams E, Tanner C, Meshman J, Saini I, et al. Acute calcineurin inhibitor nephrotoxicity secondary to turmeric intake: a case report. Transplant Proc. 2017;49:198–200.

    Article  CAS  PubMed  Google Scholar 

  28. Carbajal R, Yisfalem A, Pradhan N, Baumstein D, Chaudhari A. Case report: Boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. Transplant Proc. 2014;46:2400–2.

    Article  CAS  PubMed  Google Scholar 

  29. Rivera CA, Ferro CL, Busua AJ, Gerber BS. Probable interaction between Lycium barbarum (Goji) and warfarin. Pharmacotherapy. 2012;32:e50-53.

    Article  PubMed  Google Scholar 

  30. Zhang J, Tian L, Xie B. Bleeding due to a probable interaction between warfarin and Gouqizi (Lycium Barbarum L.). Toxicol Rep. 2015;2:1209–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sorbera M, Joseph T, DiGregorio RV. Elevated international normalized ratio in a patient taking warfarin and mauby: a case report. J Pharm Pract. 2017;30:567–70.

    Article  PubMed  Google Scholar 

  32. Tamura S, Warabi Y, Matsubara S. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement. J Clin Pharm Ther. 2012;37:724–5.

    Article  CAS  PubMed  Google Scholar 

  33. Myers AP, Watson TA, Strock SB. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction. Pharmacotherapy. 2015;35:e9-12.

    Article  CAS  PubMed  Google Scholar 

  34. Kang Y-C, Chen M-H, Lai S-L. Potentially unsafe herb-drug interactions between a commercial product of noni juice and phenytoin: a case report. Acta Neurol Taiwan. 2015;24:43–6.

    PubMed  Google Scholar 

  35. Khalid Z, Osuagwu FC, Shah B, Roy N, Dillon JE, Bradley R. Celery root extract as an inducer of mania induction in a patient on venlafaxine and St John’s Wort. Postgrad Med. 2016;128:682–3.

    Article  PubMed  Google Scholar 

  36. Hughes RL. Fatal combination of mitragynine and quetiapine: a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019;15:110–3.

    Article  CAS  PubMed  Google Scholar 

  37. Maniscalco I, Toffol E, Giupponi G, Conca A. The interaction of Rhodiola rosea and antidepressants: a case report. Neuropsychiatr. 2015;29:36–8.

    Article  PubMed  Google Scholar 

  38. Strippoli S, Lorusso V, Albano A, Guida M. Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin. BMC Complement Altern Med. 2013;13:199.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Jacquin-Porretaz C, Nardin C, Blanc D, Aubin F, Gérard B, Drobacheff-Thiebaut C, et al. Cutaneous toxicity induced by hibiscus tea in a patient treated with erlotinib. J Thorac Oncol. 2017;12:e47–8.

    Article  PubMed  Google Scholar 

  40. Kurtaran M, Koc NS, Aksun MS, Yildirim T, Yilmaz ŞR, Erdem Y. Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case report. Ther Adv Drug Saf. 2021;12:20420986211009360.

    Article  Google Scholar 

  41. Carter J, Yeh RF, Braunschweig I, Barta SK. Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT. Bone Marrow Transplant. 2014;49:313–4.

    Article  CAS  PubMed  Google Scholar 

  42. Ferreira PG, Costa S, Dias N, Ferreira AJ, Franco F. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J Bras Pneumol. 2014;40:313–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Malaty J, Malaty IA. Hypertensive urgency: an important aetiology of rebound hypertension. Case Rep. 2014; p bcr2014206022.

  44. Hou Q, Han W, Fu X. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome. Eur J Clin Pharmacol. 2013;69:1861–2.

    Article  PubMed  Google Scholar 

  45. Markert C, Kastner IM, Hellwig R, Kalafut P, Schweizer Y, Hoffmann MM, et al. The effect of induction of CYP3A4 by St John’s wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype. Basic Clin Pharmacol Toxicol. 2015;116:423–8.

    Article  CAS  PubMed  Google Scholar 

  46. Loughren MJ, Kharasch ED, Kelton-Rehkopf MC, Syrjala KL, Shen DD. St. John’s Wort influence on intravenous fentanyl pharmacokinetics, pharmacodynamics and clinical effects: a randomized clinical trial. Anesthesiol. 2020;132:491–503.

    Article  Google Scholar 

  47. Heger-Mahn D, Pabst G, Dienel A, Schläfke S, Klipping C. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination. Drugs R D. 2014;14:265–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Kawaguchi-Suzuki M, Frye RF, Zhu H-J, Brinda BJ, Chavin KD, Bernstein HJ, et al. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metab Dispos. 2014;42:1611–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Thronicke A, Steele ML, Grah C, Matthes B, Schad F. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement Altern Med. 2017;17:534.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Hu M, Mak VWL, Yin OQP, Chu TTW, Tomlinson B. Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin. Drug Metab Pharmacokinet. 2013;28:104–8.

    Article  CAS  PubMed  Google Scholar 

  51. Kim T-E, Ha N, Kim Y, Kim H, Lee JW, Jeon J-Y, et al. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers. Drug Des Devel Ther. 2017;11:1409–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Finco A, Belcaro G, Cesarone MR. Evaluation of oxidative stress after treatment with low estrogen contraceptive either alone or associated with specific antioxidant therapy. Contraception. 2012;85:503–8.

    Article  CAS  PubMed  Google Scholar 

  53. Anlamlert W, Sermsappasuk P, Yokubol D, Jones S. Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers. J Clin Pharmacol. 2015;55:377–83.

    Article  CAS  PubMed  Google Scholar 

  54. Toh DSL, Limenta LMG, Yee JY, Wang L-Z, Goh B-C, Murray M, et al. Effect of mushroom diet on pharmacokinetics of gabapentin in healthy Chinese subjects. Br J Clin Pharmacol. 2014;78:129–34.

    CAS  PubMed  Google Scholar 

  55. Wilson D, Goggin K, Williams K, Gerkovich MM, Gqaleni N, Syce J, et al. Consumption of Sutherlandia frutescens by HIV-seropositive South African adults: an adaptive double-blind randomized placebo controlled trial. PLoS ONE. 2015;10: e0128522.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Wang P, Sun H, Yang L, Li L-Y, Hao J, Ruff D, et al. Absence of an effect of T89 on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. J Clin Pharmacol. 2014;54:234–9.

    Article  CAS  PubMed  Google Scholar 

  57. Guo M, Wang T, Yang J, Chang H, Ji S, Tang D. Interaction of clopidogrel and fufang danshen dripping pills assay in coronary heart disease based on non-target metabolomics. J Ethnopharmacol. 2019;234:189–96.

    Article  CAS  PubMed  Google Scholar 

  58. Zhou Q, Ye Z, Ruan Z, Zeng S. Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe. J Ethnopharmacol. 2013;146:744–9.

    Article  CAS  PubMed  Google Scholar 

  59. Saruwatari J, Takaishi C, Yoshida K, Takashima A, Fujimura Y, Umemoto Y, et al. A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers. J Pharm Pharmacol. 2012;64:670–6.

    Article  CAS  PubMed  Google Scholar 

  60. Park S-I, Park J-Y, Park M-J, Yim S-V, Kim B-H. Effects of Ojeok-san on the pharmacokinetics of celecoxib at steady-state in healthy volunteers. Basic Clin Pharmacol Toxicol. 2018;123:51–7.

    Article  CAS  PubMed  Google Scholar 

  61. Tocaciu S, Oliver LJ, Lowenthal RM, Peterson GM, Patel R, Shastri M, et al. The effect of Undaria pinnatifida Fucoidan on the pharmacokinetics of letrozole and tamoxifen in patients with breast cancer. Integr Cancer Ther. 2018;17:99–105.

    Article  CAS  PubMed  Google Scholar 

  62. Kim H, Bae SK, Park S-J, Shim E-J, Kim H-S, Shon J-H, et al. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. Br J Clin Pharmacol. 2010;70:126–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, et al. The effect of yokukansan, a traditional herbal preparation used for the behavioral and psychological symptoms of dementia, on the drug-metabolizing enzyme activities in healthy male volunteers. Biol Pharm Bull. 2016;39:1468–74.

    Article  CAS  PubMed  Google Scholar 

  64. Qiu F, Liu S, Miao P, Zeng J, Zhu L, Zhao T, et al. Effects of the Chinese herbal formula “Zuojin Pill” on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype. Eur J Clin Pharmacol. 2016;72:689–95.

    Article  CAS  PubMed  Google Scholar 

  65. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med. 2005;165:281–6.

    Article  PubMed  Google Scholar 

  66. Devesa Jordà F, Pellicer Bataller J, Ferrando Ginestar J, Borghol Hariri A, Bustamante Balén M, Ortuño Cortés J, et al. Consumo de hierbas medicinales en los pacientes de consultas externas de digestivo. Gastroenterol Hepatol. 2004;27:244–9.

    Article  PubMed  Google Scholar 

  67. Xiao C-Q, Chen R, Lin J, Wang G, Chen Y, Tan Z-R, et al. Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants. Xenobiotica. 2012;42:173–8.

    Article  CAS  PubMed  Google Scholar 

  68. Al-Jenoobi FI, Al-Thukair AA, Alam MA, Abbas FA, Al-Mohizea AM, Alkharfy KM, et al. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur J Drug Metab Pharmacokinet. 2015;40:61–6.

    Article  CAS  PubMed  Google Scholar 

  69. Zadoyan G, Rokitta D, Klement S, Dienel A, Hoerr R, Gramatté T, et al. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol. 2012;68:553–60.

    Article  CAS  PubMed  Google Scholar 

  70. Malati CY, Robertson SM, Hunt JD, Chairez C, Alfaro RM, Kovacs JA, et al. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (Pgp) activity in healthy subjects. J Clin Pharmacol. 2012;52:923–9.

    Article  Google Scholar 

  71. van Breemen RB, Chen L, Tonsing-Carter A, Banuvar S, Barengolts E, Viana M, et al. Pharmacokinetic interactions of a hop dietary supplement with drug metabolism in perimenopausal and postmenopausal women. J Agric Food Chem. 2020;68:5212–20.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Moreau F, Simon N, Walther J, Dambrine M, Kosmalski G, Genay S, et al. Does DDI-predictor help pharmacists to detect drug-drug interactions and resolve medication issues more effectively? Metabolites. 2021;11:173.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21:579–85.

    Article  CAS  PubMed  Google Scholar 

  74. Showande SJ, Adegbolagun OM, Igbinoba SI, Fakeye TO. In vivo pharmacodynamic and pharmacokinetic interactions of Hibiscus sabdariffa calyces extracts with simvastatin. J Clin Pharm Ther. 2017;42:695–703.

    Article  CAS  PubMed  Google Scholar 

  75. Goey AKL, Meijerman I, Rosing H, Burgers JA, Mergui-Roelvink M, Keessen M, et al. The effect of Echinacea purpurea on the pharmacokinetics of docetaxel. Br J Clin Pharmacol. 2013;76:467–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int J Infect Dis. 2013;17:e857–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Moltó J, Valle M, Miranda C, Cedeño S, Negredo E, Clotet B. Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients. Antimicrob Agents Chemother. 2012;56:5328–31.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Fan L, Zhou G, Guo D, Liu Y-L, Chen W-Q, Liu Z-Q, et al. The Pregnane X receptor agonist St John’s Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide. Clin Pharmacokinet. 2011;50:605–11.

    Article  CAS  PubMed  Google Scholar 

  79. Wallström P, Elmståhl S, Johansson U, Östergren P-O, Hanson BS. Usage and users of natural remedies in a middle-aged population: demographic and psychosocial characteristics: results from the Malmö Diet and Cancer Study. Pharmacoepidemiol Drug Saf. 1996;5:303–14.

    Article  PubMed  Google Scholar 

  80. Salman SAB, Amrah S, Wahab MSA, Ismail Z, Ismail R, Yuen KH, et al. Modification of propranolol’s bioavailability by Eurycoma longifolia water-based extract. J Clin Pharm Ther. 2010;35:691–6.

    Article  CAS  PubMed  Google Scholar 

  81. Moltó J, Valle M, Miranda C, Cedeño S, Negredo E, Barbanoj MJ, et al. Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients. Antimicrob Agents Chemother. 2011;55:326–30.

    Article  PubMed  CAS  Google Scholar 

  82. Dai L-L, Fan L, Wu H-Z, Tan Z-R, Chen Y, Peng X-D, et al. Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and Ginkgo biloba extracts in healthy subjects. Xenobiotica. 2013;43:862–7.

    Article  CAS  PubMed  Google Scholar 

  83. Kim H-S, Kim G, Yeo C-W, Oh M, Ghim J, Shon J-H, et al. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. Br J Clin Pharmacol. 2014;77:821–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Bedada SK, Neerati P. Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers. Phytother Res. 2016;30:463–8.

    Article  CAS  PubMed  Google Scholar 

  85. Stage TB, Pedersen RS, Damkier P, Christensen MMH, Feddersen S, Larsen JT, et al. Intake of St John’s wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone. Br J Clin Pharmacol. 2015;79:298–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacotherapy and Pharmaceutics (DPP), Université Libre de Bruxelles (ULB), Boulevard du Triomphe, CP 205/07, Access 2, Campus de la Plaine, Building BC, 1050, Bruxelles, Belgium

    Anthony Cnudde & Florence Souard

  2. Machine Learning Group, Université Libre de Bruxelles (ULB), Bruxelles, Belgium

    Anthony Cnudde

  3. Cental, UCLouvain, Louvain La Neuve, Belgium

    Patrick Watrin

Authors
  1. Anthony Cnudde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Watrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florence Souard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florence Souard.

Ethics declarations

Funding

No external funding was used in the preparation of this manuscript.

Conflict of interest

Anthony Cnudde, Patrick Watrin, and Florence Souard declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Code availability

Not applicable.

Author contributions

All authors participated in writing, reviewing and editing this manuscript.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 62 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cnudde, A., Watrin, P. & Souard, F. HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb–Drug Interactions. Clin Pharmacokinet 61, 761–788 (2022). https://doi.org/10.1007/s40262-022-01131-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-022-01131-4

Search

Navigation